Adipokine expression and secretion by canine adipocytes: stimulation of inflammatory adipokine production by LPS and TNFalpha.
Adiposity and obesity are increasing in dogs. We have examined here the endocrine function of canine adipose tissue and the regulation of production of inflammation-related adipokines by dog adipocytes. Adiponectin, leptin, IL-6, MCP-1 and TNFalpha genes were expressed in the main adipose depots of dogs, but there were no major depot differences in mRNA levels. Each adipokine was expressed in canine adipocytes differentiated in culture and secreted into the medium (leptin undetected). IL-6, MCP-1 and TNFalpha were also expressed and secreted by preadipocytes; adiponectin and leptin were only expressed after adipocyte differentiation. The inflammatory mediators LPS and TNFalpha had major stimulatory effects on the expression and secretion of IL-6, MCP-1 and TNFalpha; there was a >5,000-fold increase in IL-6 mRNA level with LPS. IL-6 release into the medium was increased >50-fold over 24 h with LPS and TNFalpha, while MCP-1 release was increased 23- and 40-fold by TNFalpha and LPS, respectively. However, there was no effect, or small reductions, in adiponectin and leptin mRNA levels with the inflammatory mediators. Dexamethasone-stimulated leptin gene expression, had no effect on adiponectin expression, but decreased the expression and secretion of IL-6 and MCP-1. The PPARgamma agonist rosiglitazone stimulated both adiponectin and leptin expression and inhibited the expression of IL-6, MCP-1 and TNFalpha; MCP-1 secretion was reduced. These results demonstrate that canine adipocytes express and secrete key adipokines and show that adipocytes of this species are highly responsive to inflammatory mediators with the induction of major increases in the production of inflammation-related adipokines.
Ryan
Vivien H
VH
Obesity Biology Research Unit, School of Clinical Sciences, University of Liverpool, Duncan Building, Liverpool, L69 3GA, UK.
German
Alexander J
AJ
Wood
I Stuart
IS
Hunter
Leif
L
Morris
Penelope
P
Trayhurn
Paul
P
D017667:Adipocytes / Q000187:drug effects / Q000378:metabolism*; D052242:Adiponectin / Q000378:metabolism*; D000818:Animals; D000893:Anti-Inflammatory Agents; D002478:Cells, Cultured; D016207:Cytokines / Q000378:metabolism*; D003907:Dexamethasone; D004285:Dogs; D005260:Female; D007004:Hypoglycemic Agents; D020738:Leptin / Q000378:metabolism*; D008070:Lipopolysaccharides; D008297:Male; D000077154:Rosiglitazone; D045162:Thiazolidinediones; D014409:Tumor Necrosis Factor-alpha
D052242:Adiponectin; D000893:Anti-Inflammatory Agents; D016207:Cytokines; D007004:Hypoglycemic Agents; D020738:Leptin; D008070:Lipopolysaccharides; D045162:Thiazolidinediones; D014409:Tumor Necrosis Factor-alpha; D000077154:Rosiglitazone; D003907:Dexamethasone
Diabetes. 1997 Mar;46(3):342-7
9032087
Mol Cell Endocrinol. 2002 Nov 29;197(1-2):221-9
12431816
Am J Physiol Endocrinol Metab. 2005 Apr;288(4):E731-40
15562246
Biochem Biophys Res Commun. 2002 Jan 25;290(3):1084-9
11798186
Int J Obes Relat Metab Disord. 2003 Dec;27 Suppl 3:S25-8
14704740
J Clin Invest. 2003 Dec;112(12):1821-30
14679177
Science. 1993 Jan 1;259(5091):87-91
7678183
Circulation. 1999 Dec 21-28;100(25):2473-6
10604883
Nature. 2006 Dec 14;444(7121):840-6
17167471
J Clin Invest. 1996 Aug 15;98(4):1004-9
8770873
Int J Obes (Lond). 2008 Dec;32 Suppl 7:S52-4
19136991
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7265-70
12756299
Nature. 2006 Dec 14;444(7121):860-7
17167474
Diabetes. 1997 Dec;46(12):1939-44
9392477
Horm Metab Res. 2008 Dec;40(12):861-8
18792883
Diabetes. 1998 Sep;47(9):1384-91
9726225
J Nutr. 1998 Dec;128(12 Suppl):2771S-2775S
9868263
Biochem Biophys Res Commun. 2004 May 21;318(1):168-75
15110769
J Biol Chem. 2003 Nov 14;278(46):45777-84
12952969
J Biol Chem. 2000 Aug 11;275(32):24255-63
10823826
J Clin Endocrinol Metab. 1997 Aug;82(8):2542-7
9253331
Trends Endocrinol Metab. 2006 Oct;17(8):314-20
16938460
Mol Cell Endocrinol. 2000 Jan 25;159(1-2):79-88
10687854
Horm Metab Res. 2005 Aug;37(8):474-81
16138259
J Biol Chem. 1995 Jul 7;270(27):15958-61
7608151
Proc Nutr Soc. 2001 Aug;60(3):329-39
11681807
Nature. 2005 Dec 8;438(7069):803-19
16341006
Endocrinology. 2003 Sep;144(9):3765-73
12933646
Am J Physiol Endocrinol Metab. 2004 Aug;287(2):E331-9
15100092
Vet Clin Pathol. 2009 Jun;38(2):136-56
19392760
Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E941-9
14749206
J Clin Invest. 1997 Dec 1;100(11):2777-82
9389742
Pflugers Arch. 2006 Jul;452(4):418-27
16586095
J Vet Med Sci. 2001 Jan;63(1):17-23
11217057
Obes Res. 2005 Apr;13(4):662-9
15897474
Am J Vet Res. 2007 Jan;68(1):57-62
17199419
Br J Nutr. 2004 Sep;92(3):347-55
15469638
J Clin Endocrinol Metab. 2002 Dec;87(12):5662-7
12466369
Int J Obes Relat Metab Disord. 2003 Dec;27 Suppl 3:S41-5
14704743
J Nutr. 2006 Jul;136(7 Suppl):1940S-1946S
16772464
Diabetes. 2005 Aug;54(8):2460-70
16046315
Nat Med. 2001 Aug;7(8):947-53
11479628
Obes Rev. 2008 Jan;9(1):20-9
17956545
J Clin Invest. 2006 Jun;116(6):1494-505
16691291
Methods. 2001 Dec;25(4):402-8
11846609
Res Vet Sci. 2006 Apr;80(2):127-32
16051287
J Lipid Res. 2007 Sep;48(9):1905-14
17699733
Nature. 2006 Dec 14;444(7121):847-53
17167472
Eur J Endocrinol. 1996 Nov;135(5):619-25
8980166
Nat Med. 2001 Aug;7(8):941-6
11479627
Science. 2003 Sep 26;301(5641):1898-903
14512627
Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5793-6
8650171
Circulation. 2000 Sep 12;102(11):1296-301
10982546
Domest Anim Endocrinol. 2009 Nov;37(4):214-26
19674864
J Clin Invest. 2003 Dec;112(12):1796-808
14679176